Laparoscopic Sleeve Gastrectomy: a Cohort Study
Status
Conditions
Treatments
Details and patient eligibility
About
This is a prospective cohort study, which subjects were obese patients requiring LSG surgery. LSG with different gastric resection starting points (2-4cm/4-6 cm from pylorus) as intervention method. The main observation is the incidence and extent of upper gastrointestinal symptoms (such as nausea, vomiting, retching, reflux, difficulty swallowing, etc.).In addition, secondary observations include the excess weight loss (%EWL) and postoperative complications. Aim to investigate the effects of LSG surgery in different starting points of gastric resection on postoperative upper gastrointestinal symptoms.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
- Patients were accepted for surgery if they satisfied the guidelines of the Society of Chinese Gastroenterological Surgeons [body mass index (BMI) ≥40 kg/m2 or BMI ≥35 kg/m2 with at least one co-morbidity associated with obesity (type 2 diabetes, hypertension, dyslipidemia, obstructive sleep apnea), age between 18 and 60 years, and failure of conservative treatment over 2 years].
- All patients undergo preoperative upper gastrointestinal (GI) endoscopy.
Exclusion criteria
- any patient who had previously been submitted to any type of bariatric surgery;
- patient currently taking anti-nausea or GERD medications preoperatively;
- any current smokers；
- active duodenal/gastric ulcer disease；
- difficult to treat gastroesophageal reflux disease (GERD) with a large hiatal hernia；
- previous major gastrointestinal surgery；
- diagnosed or suspected malignancy；
- poorly controlled significant medical or psychiatric disorders；
- disorders such as a medical history of major pathology;
- can not be able to understand and willing to participate in this registry with signature.
Trial design
138 participants in 2 patient groups
Trial contacts and locations
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal